$WSBF
Waterstone Financial, Inc.

2020 Q1 Form 10-Q Financial Statement

#000156999420000026 Filed on May 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $19.45M $19.17M
YoY Change 1.46%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $646.0K $608.0K
YoY Change 6.25% 1.33%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $6.926M $6.236M
YoY Change 11.06%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $7.997M $8.524M
YoY Change -6.18% -5.92%
Income Tax $1.928M $1.982M
% Of Pretax Income 24.11% 23.25%
Net Earnings $6.069M $6.542M
YoY Change -7.23% -5.87%
Net Earnings / Revenue 31.2% 34.12%
Basic Earnings Per Share $0.24 $0.25
Diluted Earnings Per Share $0.24 $0.24
COMMON SHARES
Basic Shares Outstanding 25.41M 26.50M
Diluted Shares Outstanding 25.61M 26.72M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $59.12M $104.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $24.62M $33.50M
YoY Change -26.5% 48.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $2.057B $1.929B
YoY Change 6.64% 4.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $21.20M $21.20M
YoY Change 0.0% 76.67%
Deferred Revenue
YoY Change
Short-Term Debt $40.00M $18.50M
YoY Change 116.22% -4.64%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $21.20M $21.20M
YoY Change 0.0% 76.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $55.40M $37.20M
YoY Change 48.92% 74.65%
Total Long-Term Liabilities $55.40M $37.20M
YoY Change 48.92% 74.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.20M $21.20M
Total Long-Term Liabilities $55.40M $37.20M
Total Liabilities $1.685B $1.544B
YoY Change 9.11% 7.1%
SHAREHOLDERS EQUITY
Retained Earnings $187.8M
YoY Change
Common Stock $263.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $371.8M $384.5M
YoY Change
Total Liabilities & Shareholders Equity $2.057B $1.929B
YoY Change 6.64% 4.86%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $6.069M $6.542M
YoY Change -7.23% -5.87%
Depreciation, Depletion And Amortization $646.0K $608.0K
YoY Change 6.25% 1.33%
Cash From Operating Activities -$37.66M $17.76M
YoY Change -312.02% -10.28%
INVESTING ACTIVITIES
Capital Expenditures $241.0K $330.0K
YoY Change -26.97% -265.0%
Acquisitions
YoY Change
Other Investing Activities -$14.90M $3.300M
YoY Change -551.52% -123.4%
Cash From Investing Activities -$15.18M $2.944M
YoY Change -615.52% -120.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $14.25M $7.969M
YoY Change 78.76%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 37.66M -1.976M
YoY Change -2006.07% -106.74%
NET CHANGE
Cash From Operating Activities -37.66M 17.76M
Cash From Investing Activities -15.18M 2.944M
Cash From Financing Activities 37.66M -1.976M
Net Change In Cash -15.18M 18.73M
YoY Change -181.02% -46.17%
FREE CASH FLOW
Cash From Operating Activities -$37.66M $17.76M
Capital Expenditures $241.0K $330.0K
Free Cash Flow -$37.90M $17.43M
YoY Change -317.41% -12.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
Waterstone Financial, Inc.
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001569994
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
0
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
642000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1492000
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
198579000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
211997000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
369000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
214000
CY2019Q4 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
4212000
CY2020Q1 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
12966000
CY2020Q1 us-gaap Advertising Expense
AdvertisingExpense
900000
CY2019Q1 us-gaap Advertising Expense
AdvertisingExpense
958000
CY2019Q1 us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
67000
CY2020Q1 us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
104000
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
58000
CY2019Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
69000
CY2020Q1 us-gaap Amortization Of Esop Award
AmortizationOfESOPAward
449000
CY2019Q1 us-gaap Amortization Of Esop Award
AmortizationOfESOPAward
437000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
113000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000
CY2019Q4 us-gaap Assets
Assets
1996347000
CY2020Q1 us-gaap Assets
Assets
2056676000
CY2019Q1 us-gaap Assets
Assets
1928665000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5714000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2993000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue
13984000
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
168747000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
176903000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
3502000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
3497000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
36203000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2972000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1420000
CY2020Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
171489000
CY2019Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
178476000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenAmortizedCostBasis
10641000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenFairValue
7827000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis
13126000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
35518000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
105965000
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
109973000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
178476000
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
171489000
CY2020Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
353000
CY2019Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
344000
CY2020Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><!--Anchor-->Note 1 &#8212; Basis of Presentation</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The unaudited interim consolidated financial statements include the accounts of Waterstone Financial, Inc. (the &#8220;Company&#8221;) and the Company&#8217;s subsidiaries.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">WaterStone Bank SSB (the "Bank") is a community bank that has served the banking needs of its customers since 1921. WaterStone Bank also has an active mortgage banking subsidiary, Waterstone Mortgage Corporation.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">WaterStone Bank conducts its community banking business from 13 banking offices located in Milwaukee, Washington and Waukesha Counties, Wisconsin, as well as a loan production office in Minneapolis, Minnesota. WaterStone Bank's principal lending activity is originating one- to four-family, multi-family residential real estate, and commercial real estate loans for retention in its portfolio. WaterStone Bank also offers home equity loans and lines of credit, construction and land loans, commercial business loans, and consumer loans. WaterStone Bank funds its loan production primarily with retail deposits and Federal Home Loan Bank advances. Our deposit offerings include: certificates of deposit, money market savings accounts, transaction deposit accounts, non-interest bearing demand accounts and individual retirement accounts. Our investment securities portfolio is comprised principally of mortgage-backed securities, government-sponsored enterprise bonds and municipal obligations.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">WaterStone Bank's mortgage banking operations are conducted through its wholly-owned subsidiary, Waterstone Mortgage Corporation.&#160; Waterstone Mortgage Corporation originates single-family residential real estate loans for sale into the secondary market.&#160; Waterstone Mortgage Corporation utilizes lines of credit provided by WaterStone Bank as a primary source of funds, and also utilizes a line of credit with another financial institution as needed.</div><div><br /></div></div><div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information, Rule 10-01 of Regulation S-X and the instructions to Form 10-Q. The financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments (consisting of normal recurring accruals) necessary to present fairly the financial position, results of operations, changes in shareholders&#8217; equity, and cash flows of the Company for the periods presented.</div><div><br /></div></div><div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The accompanying unaudited consolidated financial statements and related notes should be read in conjunction with the Company&#8217;s December 31, 2019 Annual Report on Form 10-K. Operating results for the three months ended March 31, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020 or for any other period.</div><div><br /></div></div><div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The preparation of the unaudited consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the allowance for loan losses, income taxes, and fair value measurements. Actual results could differ from those estimates.</div><div><br /></div><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Impacts of COVID-19</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In March, 2020, the World Health Organization declared the outbreak of COVID-19 as a global pandemic, which continues to spread throughout the United States and around the world. The declaration of a global pandemic indicates that almost all public commerce and related business activities must be, to varying degrees, curtailed with the goal of decreasing the rate of new infections. The outbreak of COVID-19 could adversely impact a broad range of industries in which the Company&#8217;s customers operate and impair their ability to fulfill their financial obligations to the Company. On March 3, 2020, the Federal Open Market Committee reduced the target federal funds rate by 50 basis points to 1.00% to 1.25%. This rate was further reduced to a target range of 0% to 0.25% on March 16, 2020. These reductions in interest rates and other effects of the COVID-19 outbreak may adversely affect the Company&#8217;s financial condition and results of operations. As a result of the spread of the COVID-19 coronavirus, economic uncertainties have arisen which are likely to negatively impact net interest income and noninterest income. Other financial impact could occur though such potential impact is unknown at this time.</div><div><br /></div><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Subsequent Events</div><div><br /></div><div style="text-align: justify; margin-right: 5.75pt; margin-top: 4.6pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company has evaluated subsequent events for potential recognition and/or disclosure through the date the unaudited consolidated financial statements included in this Quarterly Report on Form 10-Q were issued. There were no significant subsequent events for the quarter ended March 31, 2020 through the issuance date of these unaudited consolidated financial statements that warranted adjustment to or disclosure in the unaudited consolidated financial statements, other than that disclosed in Note 10 &#8211; Commitments, Off-Balance Sheet Arrangements and Contingent Liabilities. <br /></div><div><font style="font-style: italic;"><br /></font></div><div><font style="font-style: italic;">Reclassifications</font><br /></div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Certain prior period amounts have been reclassified to conform to current period presentation.&#160; These reclassifications did not result in any changes to previously reported net income.&#160; The Company reclassified the Cost of Shares Repurchased line item presented in prior periods to the Additional Paid in Capital line item in the Consolidated Statements of Financial Condition.&#160; The Cost of Shares Repurchased column was reclassified to the Additional Paid in Capital line in the Consolidated Statements of Changes in Shareholders&#8217; Equity.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Impact of Recent Accounting Pronouncements</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">ASC Topic 842 "Leases."</font> Authoritative accounting guidance under ASC Topic 842, "Leases" amended prior guidance to require lessees to recognize the assets and liabilities arising from all leases on the balance sheet. The authoritative guidance defines a lease as a contract, or part of a contract, that conveys the right to control the use of identified property, plant, or equipment (an identified asset) for a period of time in exchange for consideration. In addition, the qualifications for a sale and leaseback transaction have been amended. The authoritative guidance also requires qualitative and quantitative disclosures by lessees and lessors to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. The Company used a prospective approach. The Company adopted ASC 842 as of January 1, 2019 with no impact on statement of income.&#160; See the impact on the financial condition discussed in Note 15.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">ASC Topic 326 "Financial Instruments - Credit Losses."</font> Authoritative accounting guidance under ASC Topic 326, "Financial Instruments - Credit Losses" amended the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information for credit loss estimates. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The authoritative guidance also requires a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected (net of the allowance for credit losses). In addition, the credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses rather than a write-down.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was signed into law. It included an option for entities to delay the adoption of ASC Topic 326 until the earlier of the termination date of the national emergency declaration by the President or December 31, 2020. Due to the uncertainty on the economy and unemployment from COVID-19, the Company has determined to delay its adoption of ASU 2016-13 and has calculated and recorded its provision for loan losses under the incurred loss model that existed prior to ASU 2016-13.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company has input the available historical Company data to build an internal model and is reviewing the assumptions to support the calculation. Management&#8217;s methodology for estimating the allowance for credit losses under CECL includes the use of relevant available information, from internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts. Historical credit loss experience by vintage classified by loans with similar risk profiles provides the basis for the estimation of expected credit losses. Adjustments to historical loss information are considered for differences in current loan-specific risk characteristics such as changes in underwriting standards, portfolio mix, portfolio volume, delinquency rates, interest rates, or other relevant factors. Management will continue to review and adjust these and other factors. Ongoing evaluations have been performed by vintage adjusted for prepayments. For two portfolio segments, management expects to use a weighted average remaining maturity methodology, which contemplates loss expectations on a pool basis, relying on historic loss rates.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Management is validating the CECL model and methodologies; however we expect an initial increase to the allowance for credit loss, including reserves for unfunded commitments, not to exceed 130% of the December 31, 2019 allowance.&#160; When finalized, this one-time increase as a result of the adoption of CECL will be recorded, net of tax, as an adjustment to retained earnings effective on the earlier of the termination date of the national emergency declaration by the President or December 31, 2020. This estimate is subject to change based on continuing refinement and validation of the model and methodologies.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Financial statement users should be aware that the allowance for credit loss is, by design, inherently sensitive to changes in economic outlook, loan and lease portfolio composition, portfolio duration, and other factors.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As we continue to evaluate the provisions of ASU 2016-13 as of and for the three months ended March 31, 2020, we are considering the following in developing our forecast and its effect on our CECL calculations:</div><div><br /></div><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 36pt; vertical-align: top; align: right;"><div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: Times New Roman;">&#9679;</font></div></td><td style="width: auto; vertical-align: top;"><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Duration, extent and severity of COVID-19;</div></td></tr></table></div><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 36pt; vertical-align: top; align: right;"><div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: Times New Roman;">&#9679;</font></div></td><td style="width: auto; vertical-align: top;"><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Effect of government assistance; and</div></td></tr></table></div><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 36pt; vertical-align: top; align: right;"><div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: Times New Roman;">&#9679;</font></div></td><td style="width: auto; vertical-align: top;"><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Unemployment and effect on economies and markets.</div></td></tr></table></div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">ASC Topic 310 "Receivables - Nonrefundable Fees and Other Costs." </font>Authoritative accounting guidance under ASC Topic 310, "Receivables - Nonrefundable Fees and Other Costs" amends prior guidance by shortening the amortization period for certain callable debt securities held at a premium requiring the premium to be amortized to the earliest call date. The Company adopted ASC 310 as of January 1, 2019 with no material impact on the Company's statements of operations or financial condition.</div><div><br /></div></div></div>
CY2020Q1 us-gaap Capital
Capital
382887000
CY2019Q4 us-gaap Capital
Capital
404748000
CY2019Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.2617
CY2020Q1 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.2387
CY2020Q1 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.0800
CY2019Q4 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.0800
CY2020Q1 us-gaap Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
128310000
CY2019Q4 us-gaap Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
123731000
CY2020Q1 us-gaap Cash
Cash
41864000
CY2019Q4 us-gaap Cash
Cash
52814000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86101000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74300000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104833000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59124000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
18732000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15176000
CY2019Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
74300000
CY2020Q1 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
59124000
CY2020Q1 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
369661000
CY2019Q4 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
392361000
CY2019Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.62
CY2020Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.62
CY2020Q1 us-gaap Common Equity Tier One Capital Required For Capital Adequacy
CommonEquityTierOneCapitalRequiredForCapitalAdequacy
72174000
CY2019Q4 us-gaap Common Equity Tier One Capital Required For Capital Adequacy
CommonEquityTierOneCapitalRequiredForCapitalAdequacy
69599000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27148411
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26274974
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27148411
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26274974
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
271000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
263000
CY2020Q1 us-gaap Communication
Communication
338000
CY2019Q1 us-gaap Communication
Communication
328000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6919000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8052000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
6919000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
8052000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
18909000
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
7028000
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
2972000
CY2019Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
1420000
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
7028000
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
43661000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
24752000
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
0
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2972000
CY2019Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1263000
CY2019Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
157000
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
0
CY2020Q1 us-gaap Demand Deposit Accounts
DemandDepositAccounts
135234000
CY2019Q4 us-gaap Demand Deposit Accounts
DemandDepositAccounts
130063000
CY2019Q4 us-gaap Deposits
Deposits
1067776000
CY2020Q1 us-gaap Deposits
Deposits
1086068000
CY2019Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
197942000
CY2020Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
221464000
CY2019Q1 us-gaap Depreciation
Depreciation
608000
CY2020Q1 us-gaap Depreciation
Depreciation
646000
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15650000
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
16392000
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.241
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.233
CY2020Q1 us-gaap Fair Value Option Loans Held As Assets90 Days Or More Past Due
FairValueOptionLoansHeldAsAssets90DaysOrMorePastDue
0
CY2019Q4 us-gaap Fair Value Option Loans Held As Assets90 Days Or More Past Due
FairValueOptionLoansHeldAsAssets90DaysOrMorePastDue
0
CY2019Q4 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Collateral Pledged1
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1
21200000
CY2020Q1 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Collateral Pledged1
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1
23000000
CY2019Q4 us-gaap Federal Funds Sold
FederalFundsSold
12704000
CY2020Q1 us-gaap Federal Funds Sold
FederalFundsSold
9473000
CY2020Q1 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
22950000
CY2019Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
21150000
CY2020Q1 us-gaap Federal Home Loan Bank Advances
FederalHomeLoanBankAdvances
510000000
CY2019Q4 us-gaap Federal Home Loan Bank Advances
FederalHomeLoanBankAdvances
470000000
CY2020Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
1076000
CY2019Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
805000
CY2019Q1 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
23359000
CY2020Q1 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
30406000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
6465000
CY2020Q1 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
11025000
CY2020Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
10
CY2019 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
11
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
7000
CY2019Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
32000
CY2020Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
3929000
CY2019Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
4018000
CY2019Q1 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
CY2020Q1 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
CY2019Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
2000000
CY2020Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
1200000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
1381566000
CY2020Q1 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
1398353000
CY2019Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1377974000
CY2020Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1399559000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
39000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
31000
CY2020Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
9819000
CY2019Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
10057000
CY2019Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
24000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
61000
CY2018Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
13249000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
12387000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
13226000
CY2019Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
12561000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
13195000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
12348000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
236000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
37000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
48000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
47000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
29000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
40000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
35000
CY2020Q1 us-gaap Foreclosed Assets
ForeclosedAssets
2300000
CY2019Q4 us-gaap Foreclosed Assets
ForeclosedAssets
2300000
CY2019Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
12000
CY2020Q1 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
5000
CY2019Q1 us-gaap Gain Loss On Sale Of Loans And Leases
GainLossOnSaleOfLoansAndLeases
23551000
CY2020Q1 us-gaap Gain Loss On Sale Of Loans And Leases
GainLossOnSaleOfLoansAndLeases
31837000
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
9879000
us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
12409000
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod
14000
us-gaap Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod
44000
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
9139000
us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
9658000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
3270000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
221000
us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
183000
us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
137000
CY2020Q1 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
217000
CY2019Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
224000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
11680000
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
11443000
CY2020Q1 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
626000
CY2019Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
633000
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
9602000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
9833000
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod
139000
us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod
123000
CY2019Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
10057000
CY2020Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
9819000
CY2019Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
39000
CY2020Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
31000
CY2020Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
12069000
CY2019Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
12313000
CY2017Q4 us-gaap Incentive Fee Expense
IncentiveFeeExpense
20000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8524000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
7997000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1982000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1928000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1791000
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1238000
CY2019Q1 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-3922000
CY2020Q1 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
-3040000
CY2019Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
357000
CY2020Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
147000
CY2020Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-38000
CY2019Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
33000
CY2020Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
18292000
CY2019Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-1154000
CY2020Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-96000
CY2020Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
19452000
CY2020Q1 us-gaap Interest Expense
InterestExpense
6926000
CY2019Q1 us-gaap Interest Expense
InterestExpense
6236000
CY2020Q1 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
2608000
CY2019Q1 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
2246000
CY2020Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
4318000
CY2019Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
3990000
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
12526000
CY2019Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
12936000
CY2019Q1 us-gaap Interest Income Securities State And Municipal
InterestIncomeSecuritiesStateAndMunicipal
1309000
CY2020Q1 us-gaap Interest Income Securities State And Municipal
InterestIncomeSecuritiesStateAndMunicipal
1063000
CY2019Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-122000
CY2019Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
8882000
CY2020Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
2968000
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
221000
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
207000
CY2019Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
769000
CY2020Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1006000
CY2019Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
17104000
CY2020Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
17687000
CY2019Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
19172000
CY2019Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
13616000
CY2020Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
11741000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
6203000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
6964000
CY2020Q1 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
702000
CY2019Q1 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
759000
CY2019Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
8782000
CY2020Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
7787000
CY2020Q1 us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
481000
CY2019Q1 us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
379000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
961000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3026000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1106000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
325000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9276000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1080000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1609000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2249000
CY2019Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
20639000
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
24401000
CY2020Q1 us-gaap Lease Cost
LeaseCost
1126000
CY2019Q1 us-gaap Lease Cost
LeaseCost
1251000
CY2017Q4 us-gaap Legal Fees
LegalFees
3298851
CY2019Q4 us-gaap Liabilities
Liabilities
1602661000
CY2020Q1 us-gaap Liabilities
Liabilities
1684850000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1996347000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2056676000
CY2020Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
35000000
CY2020Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
13226000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
12387000
CY2019Q4 us-gaap Loans And Leases Receivable Collateral For Secured Borrowings
LoansAndLeasesReceivableCollateralForSecuredBorrowings
1070000
CY2020Q1 us-gaap Loans And Leases Receivable Collateral For Secured Borrowings
LoansAndLeasesReceivableCollateralForSecuredBorrowings
1080000
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1388031000
CY2020Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1409378000
CY2019Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
6300000
CY2020Q1 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
6300000
CY2019Q4 us-gaap Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
7025000
CY2020Q1 us-gaap Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
6802000
CY2019Q4 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
220123000
CY2020Q1 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
262736000
CY2020Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1396152000
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1375644000
CY2019Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1388031000
CY2020Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1409378000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
483562000
CY2020Q1 us-gaap Long Term Debt
LongTermDebt
522180000
CY2017Q4 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
7267919
CY2019Q2 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
55000
CY2019Q2 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
89
CY2020Q1 us-gaap Mortgage Loans On Real Estate Other Additions
MortgageLoansOnRealEstateOtherAdditions
0
CY2019Q1 us-gaap Mortgage Loans On Real Estate Other Additions
MortgageLoansOnRealEstateOtherAdditions
0
CY2020Q1 us-gaap Mortgage Loans On Real Estate Foreclosures
MortgageLoansOnRealEstateForeclosures
0
CY2019Q1 us-gaap Mortgage Loans On Real Estate Foreclosures
MortgageLoansOnRealEstateForeclosures
30000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17764000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37663000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2944000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15177000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37664000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1976000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
6542000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
6069000
CY2019Q1 us-gaap Noninterest Income
NoninterestIncome
24257000
CY2020Q1 us-gaap Noninterest Income
NoninterestIncome
31464000
CY2020Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
224000
CY2019Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
175000
CY2019Q1 us-gaap Noninterest Expense
NoninterestExpense
29349000
CY2020Q1 us-gaap Noninterest Expense
NoninterestExpense
35208000
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2020Q1 us-gaap Occupancy Net
OccupancyNet
2741000
CY2019Q1 us-gaap Occupancy Net
OccupancyNet
2776000
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y11M8D
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7700000
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
758000
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
824000
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.059
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
931000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
8196000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
850000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1510000
CY2020Q1 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions No Previous Impairment
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsNoPreviousImpairment
0
CY2019 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions No Previous Impairment
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsAdditionsNoPreviousImpairment
0
CY2018Q4 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
94000
CY2019Q4 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
94000
CY2020Q1 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
1800000
CY2019Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
756000
CY2020Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
21293000
CY2019Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
491239000
CY2020Q1 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
94000
CY2020Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
687694000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
850000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1510000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-319000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-565000
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
47111000
CY2020Q1 us-gaap Other Liabilities
OtherLiabilities
63636000
CY2020Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2903000
CY2019Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2347000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
850000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1510000
CY2019Q1 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
0
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
14245000
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7969000
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2628000
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2414000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
330000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
241000
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2500000
CY2019Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0
CY2019Q1 us-gaap Payments To Acquire Mortgage Backed Securities Mbs Categorized As Available For Sale
PaymentsToAcquireMortgageBackedSecuritiesMBSCategorizedAsAvailableForSale
2745000
CY2020Q1 us-gaap Payments To Acquire Mortgage Backed Securities Mbs Categorized As Available For Sale
PaymentsToAcquireMortgageBackedSecuritiesMBSCategorizedAsAvailableForSale
686000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2019Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
31213000
CY2020Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
48884000
CY2019Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
13405000
CY2020Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
38618000
CY2019Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
250000
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1555000
CY2019Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
533395000
CY2020Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
676918000
CY2019Q1 us-gaap Proceeds From Sale Of Mortgage Servicing Rights Msr
ProceedsFromSaleOfMortgageServicingRightsMSR
0
CY2020Q1 us-gaap Proceeds From Sale Of Mortgage Servicing Rights Msr
ProceedsFromSaleOfMortgageServicingRightsMSR
0
CY2019Q1 us-gaap Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Available For Sale
ProceedsFromSaleOfMortgageBackedSecuritiesMBSCategorizedAsAvailableForSale
5997000
CY2020Q1 us-gaap Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Available For Sale
ProceedsFromSaleOfMortgageBackedSecuritiesMBSCategorizedAsAvailableForSale
9729000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
292000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
453000
CY2019Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
528000
CY2020Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
59000
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
1832000
CY2019Q1 us-gaap Professional Fees
ProfessionalFees
695000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
6542000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
6069000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24621000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25028000
CY2019Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-680000
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
785000
CY2019Q1 us-gaap Real Estate Owned Valuation Allowance Provision1
RealEstateOwnedValuationAllowanceProvision1
0
CY2020Q1 us-gaap Real Estate Owned Valuation Allowance Provision1
RealEstateOwnedValuationAllowanceProvision1
0
CY2019Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
748000
CY2020Q1 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
702000
CY2018Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
2152000
CY2019Q1 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
1649000
CY2020Q1 us-gaap Real Estate Investment Partnership Cost Of Sales
RealEstateInvestmentPartnershipCostOfSales
11000
CY2019Q1 us-gaap Real Estate Investment Partnership Cost Of Sales
RealEstateInvestmentPartnershipCostOfSales
32000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
187812000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
197393000
CY2019Q1 us-gaap Servicing Asset At Fair Value Additions
ServicingAssetAtFairValueAdditions
97000
CY2020Q1 us-gaap Servicing Asset At Fair Value Additions
ServicingAssetAtFairValueAdditions
58000
CY2020Q1 us-gaap Servicing Asset At Amortized Value Amortization1
ServicingAssetAtAmortizedValueAmortization1
51000
CY2019Q1 us-gaap Servicing Asset At Amortized Value Amortization1
ServicingAssetAtAmortizedValueAmortization1
10000
CY2019Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
282000
CY2018Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
109000
CY2020Q1 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
289000
CY2019Q1 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
196000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
214000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
369000
CY2020Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
193000
CY2019Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
233000
CY2020Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
40000000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
453000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
292000
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
14245000
CY2019Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
7969000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
393686000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
371826000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
399679000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
384468000
CY2019Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.2537
CY2019Q4 us-gaap Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.0600
CY2019Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.0400
CY2020Q1 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.0400
CY2020Q1 us-gaap Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
80491000
CY2019Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
79691000
CY2020Q1 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
369661000
CY2019Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
392361000
CY2020Q1 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.1837
CY2019Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.1969
CY2019Q4 us-gaap Tier One Risk Based Capital Required For Capital Adequacy
TierOneRiskBasedCapitalRequiredForCapitalAdequacy
92799000
CY2019Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
392361000
CY2020Q1 us-gaap Time Deposit Maturities Rolling Year Three
TimeDepositMaturitiesRollingYearThree
2504000
CY2020Q1 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
70400000
CY2019Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
70600000
CY2020Q1 us-gaap Time Deposit Maturities Next Rolling Twelve Months
TimeDepositMaturitiesNextRollingTwelveMonths
704255000
CY2020Q1 us-gaap Time Deposit Maturities Rolling Year Five
TimeDepositMaturitiesRollingYearFive
869000
CY2020Q1 us-gaap Time Deposit Maturities Rolling Year Four
TimeDepositMaturitiesRollingYearFour
868000
CY2020Q1 us-gaap Time Deposit Maturities Rolling Year Two
TimeDepositMaturitiesRollingYearTwo
20874000
CY2020Q1 us-gaap Time Deposits
TimeDeposits
729370000
CY2019Q4 us-gaap Time Deposits
TimeDeposits
739771000
CY2019Q1 us-gaap Transfer Of Other Real Estate
TransferOfOtherRealEstate
30000
CY2020Q1 us-gaap Transfer Of Other Real Estate
TransferOfOtherRealEstate
0
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The preparation of the unaudited consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include the allowance for loan losses, income taxes, and fair value measurements. Actual results could differ from those estimates.</div><div><br /></div><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Impacts of COVID-19</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In March, 2020, the World Health Organization declared the outbreak of COVID-19 as a global pandemic, which continues to spread throughout the United States and around the world. The declaration of a global pandemic indicates that almost all public commerce and related business activities must be, to varying degrees, curtailed with the goal of decreasing the rate of new infections. The outbreak of COVID-19 could adversely impact a broad range of industries in which the Company&#8217;s customers operate and impair their ability to fulfill their financial obligations to the Company. On March 3, 2020, the Federal Open Market Committee reduced the target federal funds rate by 50 basis points to 1.00% to 1.25%. This rate was further reduced to a target range of 0% to 0.25% on March 16, 2020. These reductions in interest rates and other effects of the COVID-19 outbreak may adversely affect the Company&#8217;s financial condition and results of operations. As a result of the spread of the COVID-19 coronavirus, economic uncertainties have arisen which are likely to negatively impact net interest income and noninterest income. Other financial impact could occur though such potential impact is unknown at this time.</div><div><br /></div><div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Subsequent Events</div><div><br /></div><div style="text-align: justify; margin-right: 5.75pt; margin-top: 4.6pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company has evaluated subsequent events for potential recognition and/or disclosure through the date the unaudited consolidated financial statements included in this Quarterly Report on Form 10-Q were issued. There were no significant subsequent events for the quarter ended March 31, 2020 through the issuance date of these unaudited consolidated financial statements that warranted adjustment to or disclosure in the unaudited consolidated financial statements, other than that disclosed in Note 10 &#8211; Commitments, Off-Balance Sheet Arrangements and Contingent Liabilities. <br /></div><div><font style="font-style: italic;"><br /></font></div><div><font style="font-style: italic;">Reclassifications</font><br /></div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Certain prior period amounts have been reclassified to conform to current period presentation.&#160; These reclassifications did not result in any changes to previously reported net income.&#160; The Company reclassified the Cost of Shares Repurchased line item presented in prior periods to the Additional Paid in Capital line item in the Consolidated Statements of Financial Condition.&#160; The Cost of Shares Repurchased column was reclassified to the Additional Paid in Capital line in the Consolidated Statements of Changes in Shareholders&#8217; Equity.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Impact of Recent Accounting Pronouncements</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">ASC Topic 842 "Leases."</font> Authoritative accounting guidance under ASC Topic 842, "Leases" amended prior guidance to require lessees to recognize the assets and liabilities arising from all leases on the balance sheet. The authoritative guidance defines a lease as a contract, or part of a contract, that conveys the right to control the use of identified property, plant, or equipment (an identified asset) for a period of time in exchange for consideration. In addition, the qualifications for a sale and leaseback transaction have been amended. The authoritative guidance also requires qualitative and quantitative disclosures by lessees and lessors to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. The Company used a prospective approach. The Company adopted ASC 842 as of January 1, 2019 with no impact on statement of income.&#160; See the impact on the financial condition discussed in Note 15.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">ASC Topic 326 "Financial Instruments - Credit Losses."</font> Authoritative accounting guidance under ASC Topic 326, "Financial Instruments - Credit Losses" amended the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information for credit loss estimates. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The authoritative guidance also requires a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected (net of the allowance for credit losses). In addition, the credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses rather than a write-down.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was signed into law. It included an option for entities to delay the adoption of ASC Topic 326 until the earlier of the termination date of the national emergency declaration by the President or December 31, 2020. Due to the uncertainty on the economy and unemployment from COVID-19, the Company has determined to delay its adoption of ASU 2016-13 and has calculated and recorded its provision for loan losses under the incurred loss model that existed prior to ASU 2016-13.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company has input the available historical Company data to build an internal model and is reviewing the assumptions to support the calculation. Management&#8217;s methodology for estimating the allowance for credit losses under CECL includes the use of relevant available information, from internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts. Historical credit loss experience by vintage classified by loans with similar risk profiles provides the basis for the estimation of expected credit losses. Adjustments to historical loss information are considered for differences in current loan-specific risk characteristics such as changes in underwriting standards, portfolio mix, portfolio volume, delinquency rates, interest rates, or other relevant factors. Management will continue to review and adjust these and other factors. Ongoing evaluations have been performed by vintage adjusted for prepayments. For two portfolio segments, management expects to use a weighted average remaining maturity methodology, which contemplates loss expectations on a pool basis, relying on historic loss rates.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Management is validating the CECL model and methodologies; however we expect an initial increase to the allowance for credit loss, including reserves for unfunded commitments, not to exceed 130% of the December 31, 2019 allowance.&#160; When finalized, this one-time increase as a result of the adoption of CECL will be recorded, net of tax, as an adjustment to retained earnings effective on the earlier of the termination date of the national emergency declaration by the President or December 31, 2020. This estimate is subject to change based on continuing refinement and validation of the model and methodologies.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Financial statement users should be aware that the allowance for credit loss is, by design, inherently sensitive to changes in economic outlook, loan and lease portfolio composition, portfolio duration, and other factors.</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As we continue to evaluate the provisions of ASU 2016-13 as of and for the three months ended March 31, 2020, we are considering the following in developing our forecast and its effect on our CECL calculations:</div><div><br /></div><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 36pt; vertical-align: top; align: right;"><div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: Times New Roman;">&#9679;</font></div></td><td style="width: auto; vertical-align: top;"><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Duration, extent and severity of COVID-19;</div></td></tr></table></div><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 36pt; vertical-align: top; align: right;"><div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: Times New Roman;">&#9679;</font></div></td><td style="width: auto; vertical-align: top;"><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Effect of government assistance; and</div></td></tr></table></div><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;"><tr><td style="width: 36pt; vertical-align: top; align: right;"><div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-family: Times New Roman;">&#9679;</font></div></td><td style="width: auto; vertical-align: top;"><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Unemployment and effect on economies and markets.</div></td></tr></table></div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">ASC Topic 310 "Receivables - Nonrefundable Fees and Other Costs." </font>Authoritative accounting guidance under ASC Topic 310, "Receivables - Nonrefundable Fees and Other Costs" amends prior guidance by shortening the amortization period for certain callable debt securities held at a premium requiring the premium to be amortized to the earliest call date. The Company adopted ASC 310 as of January 1, 2019 with no material impact on the Company's statements of operations or financial condition.</div><div><br /></div></div></div>
CY2020Q1 us-gaap Valuation Allowance For Impairment Of Recognized Servicing Assets Balance
ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance
53000
CY2019Q1 us-gaap Valuation Allowance For Impairment Of Recognized Servicing Assets Balance
ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance
57000
CY2019Q1 us-gaap Variable Lease Cost
VariableLeaseCost
260000
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
109000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25405000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26499000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25612000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26720000
CY2020Q1 wsbf Csv Of Line Insurance
CsvOfLineInsurance
70018000
CY2019Q4 wsbf Csv Of Line Insurance
CsvOfLineInsurance
69665000
CY2020Q1 wsbf Unearned Esop Shares Cost
UnearnedESOPSharesCost
16320000
CY2019Q4 wsbf Unearned Esop Shares Cost
UnearnedESOPSharesCost
16617000
CY2020Q1 wsbf Amortization Of Unearned Esop Award
AmortizationOfUnearnedESOPAward
449000
CY2019Q1 wsbf Amortization Of Unearned Esop Award
AmortizationOfUnearnedESOPAward
437000
CY2020Q1 wsbf Dividends Declared But Not Paid In Other Liabilities
DividendsDeclaredButNotPaidInOtherLiabilities
16737000
CY2019Q1 wsbf Dividends Declared But Not Paid In Other Liabilities
DividendsDeclaredButNotPaidInOtherLiabilities
17562000
CY2020Q1 wsbf Deferred Taxes Cash Flow
DeferredTaxesCashFlow
40000
CY2019Q1 wsbf Deferred Taxes Cash Flow
DeferredTaxesCashFlow
1187000
CY2020Q1 wsbf Minimum Number Of Consecutive Contractual Payments Received Prior To Consideration For Return To Accrual Status
MinimumNumberOfConsecutiveContractualPaymentsReceivedPriorToConsiderationForReturnToAccrualStatus
6
CY2020Q1 wsbf Number Of Loans Modified As Troubled Debt Restructuring
NumberOfLoansModifiedAsTroubledDebtRestructuring
CY2019Q1 wsbf Number Of Loans Modified As Troubled Debt Restructuring
NumberOfLoansModifiedAsTroubledDebtRestructuring
CY2020Q1 wsbf Valuation Allowance With Respect To Troubled Debt Restructurings
ValuationAllowanceWithRespectToTroubledDebtRestructurings
2000
CY2019Q4 wsbf Valuation Allowance With Respect To Troubled Debt Restructurings
ValuationAllowanceWithRespectToTroubledDebtRestructurings
7000
CY2020Q1 wsbf Loans Receivable Modifications Loans Performing In Accordance With Modified Terms
LoansReceivableModificationsLoansPerformingInAccordanceWithModifiedTerms
3927000
CY2019Q4 wsbf Loans Receivable Modifications Loans Performing In Accordance With Modified Terms
LoansReceivableModificationsLoansPerformingInAccordanceWithModifiedTerms
3570000
CY2020Q1 wsbf Loans Receivable Modifications Loans In Default
LoansReceivableModificationsLoansInDefault
2000
CY2019Q4 wsbf Loans Receivable Modifications Loans In Default
LoansReceivableModificationsLoansInDefault
448000
CY2019Q4 wsbf Loans Receivable Modifications In Default Number
LoansReceivableModificationsInDefaultNumber
2
CY2020Q1 wsbf Loans Receivable Modifications In Default Number
LoansReceivableModificationsInDefaultNumber
1
CY2019Q4 wsbf Number Of Loans Performing In Accordance With Modified Terms
NumberOfLoansPerformingInAccordanceWithModifiedTerms
9
CY2020Q1 wsbf Number Of Loans Performing In Accordance With Modified Terms
NumberOfLoansPerformingInAccordanceWithModifiedTerms
9
CY2020Q1 wsbf Number Of Loans Total
NumberOfLoansTotal
10
CY2019Q4 wsbf Number Of Loans Total
NumberOfLoansTotal
11
CY2020Q1 wsbf Loans Receivable Modifications Total
LoansReceivableModificationsTotal
3929000
CY2019Q4 wsbf Loans Receivable Modifications Total
LoansReceivableModificationsTotal
4018000
CY2020Q1 wsbf Ratio Of Total Non Accrual Loans To Total Loans Net Of Allowance
RatioOfTotalNonAccrualLoansToTotalLoansNetOfAllowance
0.0048
CY2019 wsbf Ratio Of Total Non Accrual Loans To Total Loans Net Of Allowance
RatioOfTotalNonAccrualLoansToTotalLoansNetOfAllowance
0.0051
CY2020Q1 wsbf Ratio Of Total Non Accrual Loans To Total Assets
RatioOfTotalNonAccrualLoansToTotalAssets
0.0033
CY2019 wsbf Ratio Of Total Non Accrual Loans To Total Assets
RatioOfTotalNonAccrualLoansToTotalAssets
0.0035
CY2020Q1 wsbf Percentage Of Carrying Value Of Qualifying Home Equity Loans
PercentageOfCarryingValueOfQualifyingHomeEquityLoans
0.75
CY2020Q1 wsbf Percentage Of Carrying Value Of Qualifying One To Four Family Loans
PercentageOfCarryingValueOfQualifyingOneToFourFamilyLoans
0.8
CY2020Q1 wsbf Percentage Of Carrying Value Of Qualifying Multi Family Loans
PercentageOfCarryingValueOfQualifyingMultiFamilyLoans
0.64
CY2019Q4 wsbf Number Of Loans Impaired
NumberOfLoansImpaired
0
CY2020Q1 wsbf Number Of Loans Impaired
NumberOfLoansImpaired
0
CY2020Q1 wsbf Minimum Capital Adequacy With Capital Buffer
MinimumCapitalAdequacyWithCapitalBuffer
168406000
CY2019Q4 wsbf Minimum Capital Adequacy With Capital Buffer
MinimumCapitalAdequacyWithCapitalBuffer
162398000
CY2019Q4 wsbf Tier One Risk Based Capital Required For Minimum Capital Adequacy With Capital Buffer
TierOneRiskBasedCapitalRequiredForMinimumCapitalAdequacyWithCapitalBuffer
131465000
CY2020Q1 wsbf Common Equity Tier I Capital To Risk Weighted Assets Minimum Capital Adequacy With Capital Buffer
CommonEquityTierICapitalToRiskWeightedAssetsMinimumCapitalAdequacyWithCapitalBuffer
112271000
CY2019Q4 wsbf Common Equity Tier I Capital To Risk Weighted Assets Minimum Capital Adequacy With Capital Buffer
CommonEquityTierICapitalToRiskWeightedAssetsMinimumCapitalAdequacyWithCapitalBuffer
108265000
CY2019Q4 wsbf Capital Required For Minimum Capital Adequacy With Capital Buffer To Risk Weighted Assets
CapitalRequiredForMinimumCapitalAdequacyWithCapitalBufferToRiskWeightedAssets
0.1050
CY2020Q1 wsbf Capital Required For Minimum Capital Adequacy With Capital Buffer To Risk Weighted Assets
CapitalRequiredForMinimumCapitalAdequacyWithCapitalBufferToRiskWeightedAssets
0.1050
CY2019Q4 wsbf Tier One Risk Based Capital Required For Minimum Capital Adequacy With Capital Buffer To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForMinimumCapitalAdequacyWithCapitalBufferToRiskWeightedAssets
0.0850
CY2019Q4 wsbf Common Equity Tier I Capital To Risk Weighted In Hundredths Minimum Capital Adequacy With Capital Buffer
CommonEquityTierICapitalToRiskWeightedInHundredthsMinimumCapitalAdequacyWithCapitalBuffer
0.0700
CY2020Q1 wsbf Common Equity Tier I Capital To Risk Weighted In Hundredths Minimum Capital Adequacy With Capital Buffer
CommonEquityTierICapitalToRiskWeightedInHundredthsMinimumCapitalAdequacyWithCapitalBuffer
0.0700
CY2019Q4 wsbf Common Equity Tier1 Capital To Risk Weighted Assets
CommonEquityTier1CapitalToRiskWeightedAssets
0.2537
CY2020Q1 wsbf Common Equity Tier1 Capital To Risk Weighted Assets
CommonEquityTier1CapitalToRiskWeightedAssets
0.2305
CY2020Q1 wsbf Common Equity Tier I Capital To Risk Weighted Capital Adequacy
CommonEquityTierICapitalToRiskWeightedCapitalAdequacy
0.0450
CY2019Q4 wsbf Common Equity Tier I Capital To Risk Weighted Capital Adequacy
CommonEquityTierICapitalToRiskWeightedCapitalAdequacy
0.0450
CY2020Q1 wsbf Period Of Home Equity Loans Available To The Borrower
PeriodOfHomeEquityLoansAvailableToTheBorrower
P10Y
CY2020Q1 wsbf Amortized Cost
AmortizedCost
116000
CY2020Q1 wsbf Impaired Financing Receivable With No Related Allowance Reduce Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceReduceUnpaidPrincipalBalance
1800000
CY2020Q1 wsbf Period Of Time Sales Of Real Estate Owned Fair Value Is Based
PeriodOfTimeSalesOfRealEstateOwnedFairValueIsBased
P2Y
CY2020Q1 wsbf Loans Requiring Officers Loans Committee Review And Approval Minimum
LoansRequiringOfficersLoansCommitteeReviewAndApprovalMinimum
500000
CY2020Q1 wsbf Minimum Amount Of Potential Loan Exposure To Be Reviewed By Credit Management Personnel
MinimumAmountOfPotentialLoanExposureToBeReviewedByCreditManagementPersonnel
1000000
CY2019Q4 wsbf Total Impaired Loans With Reserve Reserve
TotalImpairedLoansWithReserveReserve
39000
CY2020Q1 wsbf Total Impaired Loans With Reserve Reserve
TotalImpairedLoansWithReserveReserve
31000
CY2019Q4 wsbf Total Impaired Loans With No Reserve Reserve
TotalImpairedLoansWithNoReserveReserve
0
CY2020Q1 wsbf Total Impaired Loans With No Reserve Reserve
TotalImpairedLoansWithNoReserveReserve
0
CY2020Q1 wsbf Maximum Period Of Time Loan Reviewed Under Renewal Condition
MaximumPeriodOfTimeLoanReviewedUnderRenewalCondition
P1Y
CY2020Q1 wsbf Total Impaired Loans Cumulative Charge Offs
TotalImpairedLoansCumulativeChargeOffs
2250000
CY2019Q4 wsbf Total Impaired Loans Cumulative Charge Offs
TotalImpairedLoansCumulativeChargeOffs
2256000
CY2019Q4 wsbf Total Impaired Loans With Reserve Cumulative Charge Offs
TotalImpairedLoansWithReserveCumulativeChargeOffs
409000
CY2020Q1 wsbf Total Impaired Loans With Reserve Cumulative Charge Offs
TotalImpairedLoansWithReserveCumulativeChargeOffs
409000
CY2019Q4 wsbf Total Impaired Loans With No Reserve Cumulative Charge Offs
TotalImpairedLoansWithNoReserveCumulativeChargeOffs
1847000
CY2020Q1 wsbf Total Impaired Loans With No Reserve Cumulative Charge Offs
TotalImpairedLoansWithNoReserveCumulativeChargeOffs
1841000
CY2020Q1 wsbf Loans Originated For Sale Residential
LoansOriginatedForSaleResidential
687690000
CY2020Q1 wsbf Sales Of Loans Held For Sale
SalesOfLoansHeldForSale
676920000
CY2020Q1 wsbf Servicing Asset At Amortized Cost Net Of Valuation Allowance
ServicingAssetAtAmortizedCostNetOfValuationAllowance
236000
CY2019Q1 wsbf Servicing Asset At Amortized Cost Net Of Valuation Allowance
ServicingAssetAtAmortizedCostNetOfValuationAllowance
139000
CY2020Q1 wsbf Generated Mortgage Banking Income
GeneratedMortgageBankingIncome
30400000
CY2019Q4 wsbf Loans Sold On Servicing Retained Basis
LoansSoldOnServicingRetainedBasis
64900000
CY2020Q1 wsbf Loans Sold On Servicing Retained Basis
LoansSoldOnServicingRetainedBasis
72500000
CY2019Q1 wsbf Real Estate Sales
RealEstateSales
533000
CY2020Q1 wsbf Real Estate Sales
RealEstateSales
46000
CY2019Q1 wsbf Segment Loan Processing Expense
SegmentLoanProcessingExpense
805000
CY2020Q1 wsbf Segment Loan Processing Expense
SegmentLoanProcessingExpense
1076000
CY2019Q1 wsbf Real Estate Owned Change In Fair Value
RealEstateOwnedChangeInFairValue
0
CY2020Q1 wsbf Real Estate Owned Change In Fair Value
RealEstateOwnedChangeInFairValue
0
CY2019Q4 wsbf Loans And Leases Receivable Impaired Specific Reserve
LoansAndLeasesReceivableImpairedSpecificReserve
39000000
CY2020Q1 wsbf Loans And Leases Receivable Impaired Specific Reserve
LoansAndLeasesReceivableImpairedSpecificReserve
31000000000
CY2020Q1 wsbf Loans And Leases Receivable Impaired Outstanding Balance
LoansAndLeasesReceivableImpairedOutstandingBalance
217000000000
CY2019Q4 wsbf Loans And Leases Receivable Impaired Outstanding Balance
LoansAndLeasesReceivableImpairedOutstandingBalance
224000000
CY2020Q1 wsbf Number Of Branch Locations
NumberOfBranchLocations
2
CY2020Q1 wsbf Loss Contingency Damages To Be Paid Value
LossContingencyDamagesToBePaidValue
14952

Files In Submission

Name View Source Status
0001569994-20-000026-index-headers.html Edgar Link pending
0001569994-20-000026-index.html Edgar Link pending
0001569994-20-000026.txt Edgar Link pending
0001569994-20-000026-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wsbf-20200331.xml Edgar Link completed
wsbf-20200331.xsd Edgar Link pending
wsbf-20200331_cal.xml Edgar Link unprocessable
wsbf-20200331_def.xml Edgar Link unprocessable
wsbf-20200331_lab.xml Edgar Link unprocessable
wsbf-20200331_pre.xml Edgar Link unprocessable